Expression of peroxisome proliferator-activated receptor (PPAR) in human prostate cancer

Prostate

Volumn 51, Issue 2, 2002, Pages 108-116

  Segawa, Yoshihiro ^a   Yoshimura, Rikio ^a   Hase, Taro ^a   Nakatani, Tatsuya ^a   Wada, Seiji ^a   Kawahito, Yutaka ^b   Kishimoto, Taketoshi ^a   Sano, Hajime ^b  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Immunohistochemistry; Peroxisome proliferator activator receptors (PPAR) ; Prostate cancer; Prostatic intraepithelial neoplasia

Indexed keywords

LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; AGED; ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; CELL DIVISION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIGANDS; MALE; MIDDLE AGED; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 0036570532     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10058     Document Type: Article

References (40)

1. Microvessel quantitation and prognosis in invasive brest carcinoma
2. Tumor angiogenesis: A new significant and independent prognostic indicator in early stage brest carcinoma
3. The heparin-binding (fibroblast) growth factor family of proteins
4. Transforming growth factor-βs; chemistry, biology and therapeutics
5. Transforming growth factor-beta in rheumatoid arthritis
6. Transforming growth factor-beta production by synovial tissues from rheumatoid patients and streptococcal cell wall arthritic rats. Studies on secretion by synovial fibroblast-like cells and immunohistologic localization
7. 2, a lipid-activated transcription factor
8. Peroxisome proliferator-activated receptor (PPAR)-γ: Adipose-predominant expression and induction early in adipocyte differentiation
9. Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR-γ and C/EBP-α
10. Ligand for peroxisome proliferator-activated receptor γ (Troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo
11. Differential activation of adipogenesis by multiple PPAR isoformes
12. Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa
13. Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver
14. Expression of peroxisome proliferator-activated receptor-alpha gene is stimulated by stress and follows a diurnal rhythm
15. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-α,-β and -γ in the adult rat
16. The orphan nuclear hormone receptor LXR alpha interacts with the peroxisome proliferator-activated receptor and inhibits peroxisome proliferator signaling
17. Crosstalk between the thyroid hormone and peroxisome proliferator-activated receptors in regulating peroxisome proliferator-responsive genes
18. Tissue distribution and quantification of expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor in humans
19. Coexpression of platlet-derived growth factor-β, and fibroblast growth factor-1 in situ in synovial tissues of patients with rheumathoid arthritis and Lewis rats with adjuvant or streptococcal cell wall arthritis
20. Local serection of corticotropin-releasing hormone by enterochromaffin cells in human colon
21. Reduced risk of large-bowel adenomas among aspirin users
22. Expression of the protein product of the prostaglandin synthase-2/TIS10 gene in mitogen-stimulated Swiss 3T3 cells
23. Multiple cyclooxygenase: Cloning of a mitogen-inducible form
24. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR- and in the adult rat
25. All-trans-retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results
26. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
27. Convergence of 9-cis retiotic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors
28. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors
29. Differential expression of peroxisome proliferator-activated receptors: Tissue distribution of PPAR-α, -β and -γ in the adult rat
30. Fatty acid and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
31. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and β
32. PPAR-delta is an APC-regulated target of nonsteroidal anti-inflammatory drugs
33. Stimulation of adipogenesis in fibroblasts by PPAR-gamma 2, a lipid-activated transcription factor
34. Differential activation of peroxisome proliferator-activated receptors by eicosanoids
35. Activation of proliferator-activated receptor α and β induces apoptosis of human monocyte-derived macrophages
36. Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-delta 12, 14-prostaglandin J2
37. Terminal differentiation of human breast cancer through PPAR-γ
38. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor (PPAR)-γ agonists through induction of apoptosis
39. Expression of peroxisome proliferator-activated receptor-γ in renal cell carcinoma and growth inhibition by its agonists
40. Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model